Pfizer and Moderna have started COVID-19 vaccine trials on children as young as 6 months and ages up to 11 years old in the US and Canada. Pfizer and BioNTech also said their studies have found no serious safety concerns related to the vaccine. On Wednesday, Pfizer and BioNTech said the vaccine was 100% effective in children ages 12 to 15, which could lead the FDA to authorize the vaccine for use in adolescents in May. The vaccine is based on BioNTech proprietary mRNA technology, was jointly developed by both BioNTech and Pfizer. Further ReadingPfizer Says Its Covid-19 Vaccine Is 100% Effective In Young Teens (Forbes)Moderna And Pfizer Vaccines Prevent Infection As Well As Disease: Key Questions Remain (Forbes)Pfizer-BioNTech Covid-19 Vaccine Protects for Six Months, Companies Say (Wall Street Journal)

Source: Forbes April 01, 2021 12:21 UTC